- IRMS - Nicolae Testemitanu SUMPh
- REVISTE MEDICALE NEINSTITUȚIONALE
- The Moldovan Medical Journal
- Curierul Medical 2009 - 2016
- Curierul Medical, 2016
- Curierul Medical, 2016, Vol. 59, No 2
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/3003
Title: | Evaluation of antibiotics consumption in therapeutic intensive care department |
Authors: | Bernaz, Emilian |
Keywords: | antibiotics;defined daily dose;consumption;rational use;hospitals |
Issue Date: | 2016 |
Publisher: | Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” |
Citation: | BERNAZ, Emilian. Evaluation of antibiotics consumption in therapeutic intensive care department. In: Curierul Medical. 2016, vol. 59, no 2, pp. 5-10. ISSN 1875-0666. |
Abstract: | Background: Monitoring of aggregate, ward-supply data and analysis of the anatomical therapeutic chemical/defined daily dose system, adjusted for bed-occupancy, provides a clear picture of antibiotics consumption frequency and time-trends within hospitals and especially intensive care departments.
Material and methods: For this study we used data of a five-year (2010-2014) period, in therapeutic intensive care department of the Emergency Medicine
Institute, which show the consumption dynamics of anti-infectives for systemic use of drugs in grams and value indexes.
Results: The defined daily doses (DDD) per 1000 occupied-bed days (DDD/OBD) of antibiotics in therapeutic intensive care department decreased from
1524 in 2010 to 1206 DDD/1000 in 2014 or by 20.87%, however, it is by 11.77% higher than medium consumption of 1052.25 DDD/1000 in intensive care
units with the same activity in international hospitals. The value of 54948 lei per DDD/1000 OBD in 2010 recorded a decline to 40754 lei or by 25.84%
in 2014. The cost of one medium DDD from 36.05 lei in 2010 decreased to 33.77 lei or by 6.33% in 2014. The average antibiotics annual institution
consumption constituting 464.1 DDD/1000 in 2014 was higher by 1.06% comparatively with medium consumption of 459.20 DDD/1000 registered in
1706 international hospitals, and by 35.31% in comparison with global consumption of 343 defined daily doses per 1000 patient-days.
Conclusions: The decrease of DDD/1000 OBD and their cost took place as a result of efforts for rational use of antibiotics during the evaluated period.
Great opportunities were found for improving rational utilization of anti-infectives for systemic use. |
metadata.dc.relation.ispartof: | Curierul Medical |
URI: | http://curierulmedical.org/wp-content/uploads/2016/09/Cm-2-0-2016-PDF-Integral-3.pdf http://repository.usmf.md/handle/20.500.12710/3003 |
ISSN: | 1857-0666 |
Appears in Collections: | Curierul Medical, 2016, Vol. 59, No 2
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|